Table 3.
Association between antibiotic treatment and increased GVHD in target organs
Antibiotic | GVHD Target Organ (p value) | |||
---|---|---|---|---|
Skin (Stage 1–4) | Liver (Stage 1–4) | Upper GI (Stage 1) | Lower GI (Stage 1–4) | |
Aztreonam | 0.153 | 0.107 | 0.601 | 0.702 |
Cefepime | 0.133 | 0.183 | 0.332 | 0.514 |
Imipenem-cilastatin | 0.188 | 0.200 | 0.045 | 0.036 |
Piperacillin-tazobactam | 0.180 | 0.165 | 0.002 | 0.019 |